Login
Rafael Holdings NYSE: RFL
Rafael Holdings holds commercial real estate assets and interests in two clinical stage, oncology focused pharmaceutical companies.
| Name | Rafael Holdings |
| Ticker | RFL |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | REITs Health Care & Senior Housing |
|
Price
52W Low/High |
35.78
10.40 / 45.35 |
| Momentum | Strong Up |
| Market cap | 566 M |
| 1Y Total Return |
90.72%
Strong |
| 1Y Volatility |
92.38%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Rafael Holdings holds commercial real estate assets and interests in two clinical stage, oncology focused pharmaceutical companies.
Details
| Ticker | RFL |
| Name | Rafael Holdings |
| ISIN | US75062E1064 |
| CUSIP | 75062E106 |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | REITs Health Care & Senior Housing |
| Country | USA |
| Currency | U.S. Dollar |
Share as of 2/26/21
| Close Price | 35.78 |
| 52W Low/High | 10.40 / 45.35 |
| Market cap | 566 M |
| 1Y Total Return |
90.72%
Strong |
| 1Y Volatility |
92.38%
High Risk |
| Beta | 1.56 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -215.9% |
| Cash from Op. / Cur. Liabilities | -1.21 |
| Diluted Earnings / Share | -0.65 |
| ROE | - |
| ROIC | -8.2% |
| Price / Revenue | 119.1 |
| Price / Book | 4.9 |
| Price / CF | -88.7 |
| Current Ratio | 1.6 |
| Cur.Liabilities / Tot.Liabilities | 1.0 |
| Financial Leverage | 0.00 |
| in Mils USD |
rolling-year up to September
|
||||
|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | |
| Revenue |
5
|
5
|
4
|
5
|
|
| Gross Profit |
5
|
5
|
4
|
5
|
|
| R&D |
3
|
1
|
1
|
0
|
|
| EBITDA |
-8
|
-4
|
-1
|
-
|
|
| Operating Income |
-9
|
-7
|
-4
|
-1
|
|
| Net Income exc. Extra |
-
|
-
|
-
|
-
|
|
| per Share | |||||
| Diluted avg Shares |
16
|
16
|
13
|
-
|
|
| EPS exc. Extra |
-0.65
|
-0.41
|
-0.22
|
-
|
|
| Dividend |
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
| Total Assets |
135
|
140
|
117
|
-
|
|
| Cash, Eq & Invt ShortTerm |
7
|
11
|
30
|
-
|
|
| Total Current Assets |
8
|
12
|
34
|
-
|
|
| Total Non-Current Assets |
126
|
129
|
82
|
-
|
|
| Intangibles |
2
|
2
|
0
|
-
|
|
| Total Liabilities |
5
|
1
|
2
|
-
|
|
| Total Current Liabilities |
5
|
1
|
1
|
-
|
|
| Long Term Debt |
0
|
0
|
1
|
-
|
|
| Shareholder equity |
116
|
125
|
106
|
-
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | |
| Cash from Operations |
-6
|
-3
|
-3
|
-
|
|
| Depreciation |
2
|
2
|
2
|
-
|
|
| Cash from Investing |
3
|
-26
|
-1
|
-
|
|
| Capex |
3
|
1
|
1
|
-
|
|
| Cash from Financing |
0
|
31
|
2
|
-
|
|
| Stock Issued |
0
|
8
|
1
|
-
|
|
| Debt (LT) Issued |
0
|
18
|
0
|
-
|
|
| Free Cash Flow |
-8
|
19
|
-
|
-
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | |
| Net Profit Margin |
-
|
-
|
-
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
| Current Ratio |
1.6
|
9.7
|
46.1
|
-
|
|
| Financial Leverage D/E |
0.00
|
0.00
|
0.00
|
-
|
|
| Return on Capital Avg |
-8.2%
|
-5.2%
|
-5.4%
|
-
|
|
| Return on Shareholder Equity |
-
|
-
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available